# Ainhoa Oguiza

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ainhoa-oguiza/

## Facts

| Field | Value |
| --- | --- |
| Citations | 598 |
| Field | Atherosclerosis and Cardiovascular Diseases |
| h-index | 11 |
| i10-index | 11 |
| OpenAlex ID | https://openalex.org/A5050988363 |
| Works | 21 |

## Researcher papers

- [Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice](https://scholariq.org/papers/targeting-hsp90-ameliorates-nephropathy-and-atherosclerosis-through-suppression/)
- [Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms](https://scholariq.org/papers/nrf2-activation-provides-atheroprotection-in-diabetic-mice-through-concerted/)
- [Suppressor of Cytokine Signaling 1–Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice](https://scholariq.org/papers/suppressor-of-cytokine-signaling-1-derived-peptide-inhibits-janus-kinase-signal/)
- [SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition](https://scholariq.org/papers/socs1-targeted-therapy-ameliorates-renal-and-vascular-oxidative-stress-in/)
- [Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis](https://scholariq.org/papers/peptide-inhibitor-of-nf-b-translocation-ameliorates-experimental-atherosclerosis/)
- [Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy](https://scholariq.org/papers/suppressor-of-cytokine-signaling-1-peptidomimetic-limits-progression-of-diabetic/)
- [Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice](https://scholariq.org/papers/gene-delivery-of-suppressors-of-cytokine-signaling-socs-inhibits-inflammation/)
- [Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes](https://scholariq.org/papers/peptide-based-inhibition-of-i-b-kinase-nuclear-factor-b-pathway-protects-against/)
- [Fcγ Receptor Deficiency Attenuates Diabetic Nephropathy](https://scholariq.org/papers/fc-receptor-deficiency-attenuates-diabetic-nephropathy/)
- [Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis](https://scholariq.org/papers/interplay-between-hsp90-and-nrf2-pathways-in-diabetes-associated-atherosclerosis/)
- [Non-interventional, multicenter retrospective study of the effectiveness and safety of teduglutide in short bowel syndrome adult patients in Spain. The T-REX study](https://scholariq.org/papers/non-interventional-multicenter-retrospective-study-of-the-effectiveness-and/)

## Researcher topics

- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)
- [Heat shock proteins research](https://scholariq.org/topics/heat-shock-proteins-research/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)
- [Genomics, phytochemicals, and oxidative stress](https://scholariq.org/topics/genomics-phytochemicals-and-oxidative-stress/)
- [Galectins and Cancer Biology](https://scholariq.org/topics/galectins-and-cancer-biology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.